Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours?

Following initial success in melanoma and lung tumours, immune checkpoint inhibitors (ICIs) are now well recognized as a major immunotherapy treatment modality for multiple types of solid cancers. In colorectal cancer (CRC), the small subset that is mismatch-repair-deficient and microsatellite-insta...

Descripción completa

Detalles Bibliográficos
Autores principales: Huyghe, Nicolas, Baldin, Paméla, Van den Eynde, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034232/
https://www.ncbi.nlm.nih.gov/pubmed/32104582
http://dx.doi.org/10.1093/gastro/goz061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034232/
https://www.ncbi.nlm.nih.gov/pubmed/32104582
http://dx.doi.org/10.1093/gastro/goz061

Ejemplares similares